HF
SCPH

HRT Financial’s scPharmaceuticals SCPH Stock Holding History

HRT Financial’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,667
Closed -$154K – 3570
2025
Q2 		$154K Buy
+40,667
New +$126K ﹤0.01% 2130
2023
Q2 		– Sell
-65,198
Closed -$591K – 3172
2023
Q1 		$591K Buy
+65,198
New +$478K 0.01% 1246
2021
Q4 		– Sell
-16,189
Closed -$107K – 3971
2021
Q3 		$107K Sell
16,189
-4,072
-20% -$24.3K ﹤0.01% 2882
2021
Q2 		$123K Buy
+20,261
New +$122K ﹤0.01% 2540

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

HRT Financial's SCPH Position: Q3 2025 in Review

HRT Financial sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 40,667 shares — an estimated $154K sold.

HRT Financial first reported a position in SCPH in Q2 2021 and held it in 4 quarters. The position peaked at $591K in Q1 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

  • HRT Financial reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 40,667 scPharmaceuticals shares in Q3 2025, an estimated $154K.
  • HRT Financial first reported a position in scPharmaceuticals in Q2 2021 and held it in 4 quarters.
  • HRT Financial's scPharmaceuticals position peaked at $591K in Q1 2023.
  • 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.